Financial Instruments - Schedule of Available-for-Sale Marketable Securities (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	$ 230,818	$ 218,392
Unrealized Gain	5	78
Unrealized Losses	(2,442)	(2,544)
Fair Value	228,381	215,926
Corporate Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	176,858	184,321
Unrealized Gain	1	75
Unrealized Losses	(2,221)	(2,344)
Fair Value	174,638	182,052
U.S. treasury and agency securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	53,960	34,071
Unrealized Gain	4	3
Unrealized Losses	(221)	(200)
Fair Value	$ 53,743	$ 33,874